跳至主要内容
临床试验/NCT05892341
NCT05892341已完成不适用

A Clinical Study to Compare the Performance of AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® Dressing in the Management of Patients With Venous Leg Ulcers Over a 12-week Period

ConvaTec Inc.22 个研究点 分布在 3 个国家目标入组 203 人开始时间: 2022年12月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
ConvaTec Inc.
入组人数
203
试验地点
22
主要终点
Effectiveness of AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® on Wound Management

研究概览

简要总结

Study is to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing

详细描述

Post market, multi-centre, randomised, open label, multi-national, prospective study to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Venous insufficiency as defined by CEAP Classification of C6
  • One wound amendable to treatment with either AQUACEL® Ag+ Extra™ or Cutimed® Sorbact®
  • Wounds that have been present for at least 2 months
  • Reliable and available for follow-up
  • 18 years or older
  • Able and willing to provide informed consent
  • Able to tolerate compression therapy for Venus Leg Ulcer
  • Must be able to be compliant with compression therapy

排除标准

  • Known sensitivities or allergies to components of the AQUACEL® Ag+ Extra™ or Cutimed® Sorbact®
  • Continued use of petroleum gel/ creams/ oil-based products
  • Active treatment for cancer or completed within the last 3 months
  • Documented severe malnutrition
  • Malignant wounds
  • Systemic infection actively treated with antibiotics

研究组 & 干预措施

AQUACEL® Ag+ Extra™

Active Comparator

AQUACEL® Ag+ Extra™ is approved, needle-bonded nonwoven fabric layered and stitch-bonded wound dressing

干预措施: AQUACEL® Ag+ Extra™ (Device)

Cutimed® Sorbact®

Active Comparator

Cutimed® Sorbact® is approved, bacterial and fungi binding wound dressing

干预措施: Cutimed® Sorbact® (Device)

结局指标

主要结局

Effectiveness of AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® on Wound Management

时间窗: Up to 12 weeks

Complete wound closure as defined by 100% epithelialisation of the wound surface (Gould 2019)

次要结局

  • Wound Healing Assessment(Up to 4 weeks)
  • Wound Progress Assessment(Up to 4 weeks)
  • Wound Change Assessment(Up to 12 weeks)
  • Safety Assesment(Up to 12 weeks)

研究者

发起方
ConvaTec Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验